StockWatch
·
Pharmaceuticals
Quarterly Result13 Feb 2026, 03:57 pm

Lasa Supergenerics Ltd Announces Unaudited Financial Results for Q4 2025

AI Summary

Lasa Supergenerics Ltd has announced its unaudited financial results for the quarter ended December 31, 2025. The board of directors considered and approved these results in a meeting held on February 13, 2026. The company does not have any outstanding loans or debt securities as of December 31, 2025.

Key Highlights

  • Lasa Supergenerics Ltd has announced its unaudited financial results for Q4 2025
  • The results were approved in a board meeting held on February 13, 2026
  • The company does not have any outstanding loans or debt securities as of December 31, 2025